Verici Dx (LON:VRCI) Trading Down 2.2% – Should You Sell?

Verici Dx plc (LON:VRCI) shares dropped 2.2% on Tuesday . The stock traded as low as GBX 0.72 and last traded at GBX 0.76. Approximately 944,471 shares traded hands during mid-day trading, a decline of 55% from the average daily volume of 2,104,761 shares. The stock had previously closed at GBX 0.78.

Verici Dx Stock Down 9.0%

The stock’s 50 day moving average is GBX 0.76 and its 200 day moving average is GBX 0.75. The company has a market capitalization of £10.67 million, a PE ratio of -0.24 and a beta of 1.59. The company has a debt-to-equity ratio of 4.64, a quick ratio of 8.49 and a current ratio of 4.54.

Verici Dx Company Profile

Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.